 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Scott Veech, CFO
Richard Linden, President & CEO
414.977.4000
|
|
MERGE TECHNOLOGIES RECEIVES NASDAQ NOTIFICATION
MILWAUKEE, WI, March 23, 2006 – Merge Technologies Incorporated, d.b.a. Merge
Healthcare (NASDAQ: MRGE; TSX: MRG) (the "Company" or "Merge") today announced that
because the Company has not yet filed its Annual Report on Form 10-K for the year ended
December 31, 2005, it received a Nasdaq Staff Notification on March 20, 2006, stating that the
Company is not in compliance with Nasdaq's Marketplace Rule 4310(c)(14), and that its
securities are, therefore, subject to delisting from the Nasdaq National Market. The delisting
notification is customary when a Nasdaq listed company fails to complete a required filing in a
timely manner.
In accordance with Nasdaq rules, Merge has requested a hearing before a Nasdaq
Listing Qualifications Panel for continued listing on the Nasdaq Stock Market. No action will be
taken to delist Merge’s common stock until the Panel has completed its review, though there
can be no assurance that the Panel will grant Merge’s request for continued listing.
Richard A. Linden, President and Chief Executive Officer, stated, "We are cooperating
fully with Nasdaq and are taking all actions necessary to bring our company back into
compliance with all the listing requirements.”
Merge is working diligently to complete its Annual Report on Form 10-K and will file it as
promptly as practicable.
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information
management software and services. Our innovative software solutions use leading-edge imaging software
technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve
our customers' productivity and enhance the quality of patient care they provide. For additional information,
visit our website at www.merge.com.
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words: guidance, believes, intends, anticipates, expects, and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements based on a number of factors, including, but not limited to, risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, unexpected outcomes to any pending or future litigation, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
